SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-000994
Filing Date
2020-01-03
Accepted
2020-01-03 17:29:28
Documents
9
Period of Report
2019-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1928453-2_8k.htm 8-K 26810
2 EXHIBIT 4.1 tm1928453d2_ex4-1.htm EX-4.1 96375
3 EXHIBIT 5.1 tm1928453d2_ex5-1.htm EX-5.1 10547
4 EXHIBIT 10.1 tm1928453d2_ex10-1.htm EX-10.1 199990
5 EXHIBIT 99.1 tm1928453d2_ex99-1.htm EX-99.1 10252
6 EXHIBIT 99.2 tm1928453d2_ex99-2.htm EX-99.2 10479
7 GRAPHIC tm1928453d2_ex5-1img001.jpg GRAPHIC 3479
8 GRAPHIC tm1928453d2_ex5-1img002.jpg GRAPHIC 747
9 GRAPHIC tm1928453d2_ex5-1img003.jpg GRAPHIC 766
  Complete submission text file 0001104659-20-000994.txt   363121
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36020 | Film No.: 20506959
SIC: 2834 Pharmaceutical Preparations